why choose us

300×250 Ad Slot

Research Article: Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice

Date Published: 2023-12-08

Introduction:
A fixed combination of bictegravir/emtricitabine/tenofovir alafenamide (BFTAF, Biktarvy ® ), an HIV integrase strand transfer inhibitor (InSTI) associated with two nucleoside reverse transcriptase inhibitors, has been available in Italy since June for the treatment of people living with HIV infection (PLWH).

Read more

300×250 Ad Slot